Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pol

Showing results (41-50 of 221) with videos related to

Pageof 23
Sort By:
Gastroenterologie Clinique Et Biologique|June 8, 2001
[Treatments for hepatitis virus C infections]S Pol, H Fontaine, A Vallet-Pichard
Journal of Viral Hepatitis|February 20, 2002
Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapyS Pol, A Vallet-Pichard, H Fontaine
Gastroenterologie Clinique Et Biologique|July 23, 1999
[Prophylactic vaccination against hepatitis B: present and future]H Momméja-Marin, H Zylberberg, S Pol
HIV Medicine|August 20, 2009
Aspartate aminotransferase to platelet ratio index (APRI) score is inappropriate for assessment of liver fibrosis in HIV-infected patients with hazardous drinkingJean-Baptist Trabut, V Mallet, S Pol
Journal of Hepatology|January 6, 2000
Treatment of chronic hepatitis C in special groupsS Pol, H Zylberberg, H Fontaine, et al.
Gastroenterologie Clinique Et Biologique|August 6, 2008
[HIV and hepatitis C virus coinfection]P Cacoub, D Sène, E Rosenthal, et al.
Lancet (London, England)|November 12, 1994
Effects of interleukin-2 on hepatitis B vaccination in uraemic patientsS Pol, B Nalpas, C Legendre, et al.
Minerva Gastroenterologica E Dietologica|July 9, 2013
Rapid progression of antiviral treatments of chronic hepatitis C virus infectionS Pol, M Corouge, V Mallet, et al.
Annals of Internal Medicine|August 15, 1994
Eradication of hepatitis C virus RNA after alpha-interferon therapyR Romeo, S Pol, P Berthelot, et al.
Brain : a Journal of Neurology|April 25, 2000
Abnormal reciprocal inhibition between antagonist muscles in Parkinson's diseaseS Meunier, S Pol, J L Houeto, et al.
Pageof 23

Showing results (41-50 of 221) with videos related to

Sort By:
Pageof 23
Gastroenterologie Clinique Et Biologique|June 8, 2001
[Treatments for hepatitis virus C infections]S Pol, H Fontaine, A Vallet-Pichard
Journal of Viral Hepatitis|February 20, 2002
Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapyS Pol, A Vallet-Pichard, H Fontaine
Gastroenterologie Clinique Et Biologique|July 23, 1999
[Prophylactic vaccination against hepatitis B: present and future]H Momméja-Marin, H Zylberberg, S Pol
HIV Medicine|August 20, 2009
Aspartate aminotransferase to platelet ratio index (APRI) score is inappropriate for assessment of liver fibrosis in HIV-infected patients with hazardous drinkingJean-Baptist Trabut, V Mallet, S Pol
Journal of Hepatology|January 6, 2000
Treatment of chronic hepatitis C in special groupsS Pol, H Zylberberg, H Fontaine, et al.
Gastroenterologie Clinique Et Biologique|August 6, 2008
[HIV and hepatitis C virus coinfection]P Cacoub, D Sène, E Rosenthal, et al.
Lancet (London, England)|November 12, 1994
Effects of interleukin-2 on hepatitis B vaccination in uraemic patientsS Pol, B Nalpas, C Legendre, et al.
Minerva Gastroenterologica E Dietologica|July 9, 2013
Rapid progression of antiviral treatments of chronic hepatitis C virus infectionS Pol, M Corouge, V Mallet, et al.
Annals of Internal Medicine|August 15, 1994
Eradication of hepatitis C virus RNA after alpha-interferon therapyR Romeo, S Pol, P Berthelot, et al.
Brain : a Journal of Neurology|April 25, 2000
Abnormal reciprocal inhibition between antagonist muscles in Parkinson's diseaseS Meunier, S Pol, J L Houeto, et al.
Pageof 23